Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q2
- 저널
- INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE22(1) · pp.47 · 2018
- 피인용
- Web of Science 5Scopus 6
- FWCI (Scopus)
- 0.47
- JCR IF
- JCR 2017 2.392
- ISSN
- 1027-3719
저자
- Ei, P. W.제1저자Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar
- Aung, W. W.Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar
- Nyunt, W. W.National Tuberculosis Programme, Department of Public Health, Naypyidaw, Myanmar
- Swe, T. L.National Tuberculosis Programme, Department of Public Health, Naypyidaw, Myanmar
- Htwe, M. M.Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar
- Win, S. M.Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar
- Aung, S. T.National Tuberculosis Programme, Department of Public Health, Naypyidaw, Myanmar
- 장철훈Pusan National University Yangsan Hospital, Yangsan, South Korea
- Lee, H. Y.교신저자Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, Wonju Campus, Seoul, South Korea
- Lee, J. S.Section of Microbiology, International Tuberculosis Research Center, Masanhappo-gu, Changwon-si, Gyeongsangnam-do, South Korea
초록
SETTING: Two tuberculosis (TB) reference laboratories in Myanmar. OBJECTIVES : To determine the proportion of extensively drug-resistant TB (XDR-TB) cases among multidrug-resistant TB (MDR-TB) cases and the mutations that cause resistance to second-line drugs in Myanmar. DESIGN: This was a cross-sectional, retrospective study. Multidrug-resistant Mycobacterium tuberculosis isolates were collected during 2015-2016. Phenotypic drug susceptibility testing (DST) was performed and drug-resistant mutations identified by sequencing. Genotypes were determined to explain relationships between drug resistance patterns and genotypes. RESULTS : Of 89 MDR-TB isolates, 12 were XDR-TB and 24 were pre-XDR-TB, with 21 resistant to fluoroquinolones (FQs) and 3 to second-line injectable agents (SLIDs). High rates of cross-resistance among second-line drugs were observed. Correlations between phenotypic and molecular DST against FQs and SLIDs were 91% in both cases. The most frequent mutation in FQ-resistant isolates was D94G (8/21) in gyrA and A1401G (11/15) in rrs in those resistant to SLIDs. The dominant genotype was the Beijing type (76/89). CONCLUSION: There were high proportions of XDR-TB and pre-XDR-TB among MDR-TB cases; cross-resistance among second-line drugs was high, with various types of genetic mutations. These data suggest that resistance to second-line anti-tuberculosis drugs should be monitored intensively, and molecular DST should be employed.
키워드
MDR-TBXDR-TBpre-XDR-TBfluoroquinoloneSLIDsMYCOBACTERIUM-TUBERCULOSISCROSS-RESISTANCECAPREOMYCINKANAMYCINSTRAINSFLUOROQUINOLONEAMIKACINASSAY
식별자
- Scopus EID
- 2-s2.0-85039055497
- WoS UID
- 000429780700012



로그인
연구물 목록으로